Introduction
Noroviruses (NoVs) are considered as a major cause of acute gastroenteritis in both children and adults, being responsible for sporadic cases and outbreaks of gastroenteritis in various epidemiological settings (Green, 2007) . NoVs are small round non-enveloped viruses with a 7.5 kb single stranded positive-sense RNA that contains three open reading frames (ORFs). ORF1 encodes the non-structural proteins while ORF2 and ORF3 encode the major and minor capsid proteins, respectively (Green, 2007) .
NoV can be classified genetically into at least six genogroups, GI to GVI (Green, 2007; Martella et al., 2009) . Although more than 30 genotypes within genogroup GI, GII and GIV may infect humans ) a single genotype, GII.4, has been associated with the vast majority of NoV-related outbreaks and sporadic cases of gastroenteritis worldwide (Bok et al., 2009) . GII.4 NoV strains continuously undergo a process of genetic/antigenic diversification and periodically generate novel strains via accumulation of punctate mutations or recombination. New GII.4 variants emerge every 2-3 years Siebenga et al., 2007) . Sequence comparison, structural analysis and characterization of the antigenic and biological properties of NoV capsid protein using virus-like particles (VLPs) have revealed that the surface-exposed sub-domain P2 (residues 279 to 405) interacts with potential neutralizing antibodies and with NoV carbohydrate-binding ligands (Allen et al., 2008; Bok et al., 2009; Bull et al., 2010; de Rougemont et al., 2011; Lindesmith et al., 2008; Shanker et al., 2011; Siebenga et al., 2007) and that changes in highly variable sites (epitopes A to E) within the P2 sub-domain of GII.4 NoVs correlate with the emergence of new epidemic strains (Lindesmith et al., 2012 .
Increased incidence of NoV-related outbreaks and or illness in various countries in the late 2012 has been related to the emergence of a novel GII.4 variant, Sydney 2012. This variant was first identified in March 2012 in Australia (van Beek et al., 2013) and displayed a recombinant origin. A signature of the variant was a GII.Pe ORF1, in association with GII.4 Apeldoorn 2008-like ORF2-ORF3 genes . This novel variant in the capsid gene has a common ancestor with the NoV GII.4 variants Apeldoorn 2008 and New Orleans 2009, although phylogenetically distinct, and several amino acid changes are seen in the main epitope on the P2 sub-domain (van Beek et al., 2013 The Italian Study Group for Enteric Viruses (ISGEV; http://isgev.net) monitors the epidemiology of enteric viruses in children through hospital-based surveillance Giammanco et al., 2012; Martella et al., 2013; Medici et al., 2012) . Monitoring and characterization of NoVs is achieved by a multi-target analysis of NoV genome (Kroneman et al., 2011) and consultation of the Norovirus Typing Tool database (http://www.rivm.nl/mpf/norovirus/ typingtool). Surveillance for NoV in Italy revealed the onset of the novel pandemic variant GII.4 Sydney 2012 as early as November 2011 , and provided us with some of the earliest strains of the variant GII.4 Sydney 2012. These early strains originated from four sporadic cases occurring between November 2011 and January 2012, and a small outbreak in February 2012. However, the novel variant subsequently disappeared until the winter season 2012-2013, when it started circulating at a greater frequency . Intriguingly, our findings noted analogous observation reported from Denmark (Fonageret al., 2013) and Canada (Hasing et al., 2013) , suggesting that a period of adaptation was required for the novel variant before spreading worldwide. Analysis of early strains of this variant could be useful to understand if mutations occurred in adaptive sites or antigenic epitopes of the major capsid protein. In this study, the sequence of the GII.4 Sydney 2012 NoV strains identified in the 2011-2012 and in the 2012-2013 winter seasons in Italy was determined and compared with cognate sequences available in the databases.
Results and discussion
Epitopes A to E have been predicted based on sequence comparison and structural analysis of the P2 subdomain of GII.4 NoVs. These epitopes include mainly surface-exposed, highly variable sites surrounding the histoblood group antigen (HBGA) pocket (Lindesmith et al., 2012) . However, other residues adjacent to these putative epitopes might alter NoV strain binding affinity and specificity to HBGAs as well as antibody binding and blockade, either alone or in a coordinated manner. The GII.4 variant Sydney 2012 has been shown to have accumulated several changes in putative epitopes on the P2 sub-domain with respect to the former GII.4 variants Den Haag 2006b and New Orleans 2009 (van Beek et al., 2013) (Table 1) . Using monoclonal antibodies and VLPs in blockade assays, changes in blockade epitopes A and D of the GII.4 variant Sydney 2012 have suggested an appreciable antigenic variation from previous GII.4 variants .
By comparing the early strains of the GII.4 variant Sydney 2012, PA363/2011/ITA and PA48/2012/ITA, with cognate sequences available in the databases, at least two clades and a potential ancestor could be identified in the Bayesian phylogenetic reconstruction (Fig. 1) . A Canadian strain, AlbertaEi337/2011/CAN, identified in September 2011 (Hasing et al., 2013) While most residues in antigenic epitopes within the capsid gene (ORF2) appeared rather conserved across all the GII.4 Sydney 2012 NoV strains, polymorphisms were observed at residues 297 (Arg/His) and 372 (Asp/Asn) in epitope A and residue 393 (Gly/Ser) in epitope D (Table 1) (Siebenga et al., 2010) . Epitope B is formed by two variable residues at position 333 and 382, that are buried in the dimer interface between two chains of the capsid protein and are likely to influence exposure of residues located on more surface-exposed epitopes (Lindesmith et al., 2012) . Interestingly, residue 333 was Val in the ancestral Canadian strain AlbertaEi337/2011/CAN. This strain, although phylogenetically ancestral, already possess the same epitope asset as the strains in the major clade 2012 m of the Sydney 2012 variant, with the only exception of the change 340-Thr to Ala in epitope C. Residue 340 is also Ala in some strains within the minor phylogenetic clade 2012 e . The putative conformational epitope C is made up of two residues (340 and 376) and it is located on the surface and lateral edge of the capsid, directly proximal to the HBGA pocket (Lindesmith et al., 2012) . When comparing chronologic sets of GII.4 variants, residue 340 stands out among the variable sites (Siebenga et al., 2007) as it changes consistently across the GII.4 variants (Glu1996-Gly2002-Arg2004-Gly2006b-Thr2009-Ala/Thr2012). Accordingly, at least three residues (333, 340 and 393) mapped to three different VP1 putative epitopes, B, C and D, appeared to vary between the phylogenetic clades of the Sydney 2012 variant (Table 1) .
Conclusions
In conclusion, there is evidence that different capsid gene sublineages of the novel NoV variant GII.4 Sydney 2012 have been cocirculating globally since the late 2011. Mutations in adaptive residues at positions 333, 340 and 393 of the viral capsid protein were identified that likely played a role in the evolution/adaptation of the novel pandemic GII.4 variant. However, it may not be ruled out that other mechanisms, yet not identified, were also involved. A more in-depth understanding of the evolutionary pathway followed by GII.4 NoVs is important to predict the emergence of new pandemic strains and optimize vaccine design.
Material and methods
The GII. (Wang et al., 2005) was used to generate a 3.2 kb amplicon encompassing the 3 0 end of ORF1, the full-length ORF2 and ORF3, the 3 0 untranslated region (UTR) through the poly-A tail. Briefly, cDNA was synthesized by SuperScript III First-Strand cDNA synthesis kit (Invitrogen Ltd, Paisley, UK) with primer VN3T20 (5 0 -GAGTGACCGCGGCCGCT20-3 0 ). PCR was then performed with TaKaRa La Taq polymerase (TaKaRa Bio Europe SAS, Saint-Germain en-Laye, France) with forward primer JV12Y (Vennema et al., 2002) and the reverse primer VN3T20 (Wang et al., 2005) . The amplicons were purified and cloned using TOPO XL Cloning Kit (Invitrogen Ltd, Paisley, UK). Additional primers were designed to determine the complete 3.2-kb sequence by an overlapping strategy. Sequence editing and multiple codon-based (translation) alignments were performed with Geneious software v6.2. The sequences of the NoV strains are available in GenBank under accession numbers KF668567, KF668568, KF668569. Phylogenetic analysis and sequence comparison were performed on the full-length OFR2 sequences produced in this study and on a set of 34 complete ORF2 sequences of GII.4 Sydney 2012 NoVs retrieved from the databases. Consultation of the databases was terminated on 2 August 2013. Several algorithms were used to infer phylogenetic trees using MEGA 5.0 software (Tamura et al., 2011) and MrBayes version 3.2.1 (Huelsenbeck and Ronquist, 2001) . The appropriate substitution model settings were derived using jModelTest (Posada, 2009 ).
